Fidelis Pharmaceuticals is the proud maker of NEW Ethiqa XR™, a pharmaceutical-grade, extended-release buprenorphine that’s FDA-affirmed to control post-procedural pain for laboratory mice and ratsup to 72 hours after just one injection. Fidelis Pharmaceuticals is deeply committed to improving animal welfare with innovative new solutions for laboratory animals. The Fidelis leadership team supports the foremost veterinary, laboratory research, and human healthcare industry associations and initiatives.